Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s12872-016-0289-0
Published Online: 2016-05-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Beatch, Gregory N.
Mangal, Brian
Funding for this research was provided by:
Cardiome Pharma Corp
License valid from 2016-05-28